Artículos por temáticas

A Novel PDE10A Inhibitor for Tourette Syndrome and Other Movement Disorders

Marshall RD, Menniti FS, Tepper MA.

Cells. 2024 Jul 22;13(14):1230. doi: 10.3390/cells13141230.

The effects of Shaoma Zhijing granules and its main components on Tourette syndrome

Zhao Q, Hu Y, Yan Y, Song X, Yu J, Wang W, Zhou S, Su X, Bloch MH, Leckman JF, Chen Y, Sun H.

Phytomedicine. 2024 Jul;129:155686. doi: 10.1016/j.phymed.2024.155686. Epub 2024 Apr 26.

Novel drug treatments for pain in advanced cancer and serious illness: a focus on neuropathic pain and chemotherapy-induced peripheral neuropathy

Davis MP.

Palliat Care Soc Pract. 2024 Jul 31;18:26323524241266603. doi: 10.1177/26323524241266603. eCollection 2024.

Gilles de la Tourette syndrome as a rare co-morbidity of Klinefelter syndrome

Cavanna AE, Paini G, Purpura G, Riva A, Nacinovich R, Seri S.

Neurol Sci. 2024 Aug;45(8):4033-4035. doi: 10.1007/s10072-024-07573-x. Epub 2024 May 7.

Genome-Wide Association Study Points to Novel Locus for Gilles de la Tourette Syndrome

Tsetsos F, Topaloudi A, Jain P, Yang Z, Yu D, Kolovos P, Tumer Z, Rizzo R, Hartmann A, Depienne C, Worbe Y, Müller-Vahl KR, Cath DC, Boomsma DI, Wolanczyk T, Zekanowski C, Barta C, Nemoda Z, Tarnok Z,

Biol Psychiatry. 2024 Jul 15;96(2):114-124. doi: 10.1016/j.biopsych.2023.01.023. Epub 2023 Feb 2.

Natural history in Malan syndrome: survey of 28 adults and literature review

Huynh TN, Delagrammatikas CG, Chiriatti L, Panfili A, Ventarola K, Menke LA, Tartaglia M, Huisman SA, Priolo M.

Orphanet J Rare Dis. 2024 Jul 29;19(1):282. doi: 10.1186/s13023-024-03288-6.

Clinical neurophysiology in the treatment of movement disorders: IFCN handbook chapter

Lefaucheur JP, Moro E, Shirota Y, Ugawa Y, Grippe T, Chen R, Benninger DH, Jabbari B, Attaripour S, Hallett M, Paulus W.

Clin Neurophysiol. 2024 Aug;164:57-99. doi: 10.1016/j.clinph.2024.05.007. Epub 2024 May 23.

Movement Disorders in Patients with Subacute Sclerosing Panencephalitis: A Systematic Review

Garg D, Patel S, Sankhla CS, Holla VV, Paramanandam V, Kukkle PL, Pandey S, Schneider SA, Pal PK.

Mov Disord Clin Pract. 2024 Jul;11(7):770-785. doi: 10.1002/mdc3.14062. Epub 2024 May 15.

EXACERBATED TOURETTE SYNDROME DIAGNOSED IN ADULTHOOD AFTER RECURRENT BILATERAL RETINAL DETACHMENT

Mito T, Okemoto H, Kawasaki A, Sasaki H.

Retin Cases Brief Rep. 2024 Jul 1;18(4):488-490. doi: 10.1097/ICB.0000000000001421.

Tourette Syndrome and Neurodiversity: Pushing Through the Wrong Open Door

Dure L, Albin RL.

Neurology. 2024 Jul 23;103(2):e209641. doi: 10.1212/WNL.0000000000209641. Epub 2024 Jun 13.

Iron Supplementation in Management of Neurodevelopmental Disorders: Systematic Review, Meta-Analysis, and Qualitative Synthesis

Elliott SD, Vickers ML, McKeon G, Eriksson L, Malacova E, Scott JG.

J Neuropsychiatry Clin Neurosci. 2024 Summer;36(3):178-186. doi: 10.1176/appi.neuropsych.20230081. Epub 2024 Feb 12.

Effectiveness of a mobile application for independent computerized cognitive training in patients with mild cognitive impairment: study protocol for the NeNaE Study, a randomized controlled trial

Ferizaj D, Stamm O, Perotti L, Martin EM, Ophey A, Rekers S, Scharfenberg D, Oelgeschläger T, Barcatta K, Seiler S, Funk J, Benoy C, Finke C, Kalbe E, Finke K, Heimann-Steinert A.

Trials. 2024 Jul 3;25(1):444. doi: 10.1186/s13063-024-08277-5.

Functional brain networks associated with the urge for action: Implications for pathological urge

Zouki JJ, Eapen V, Efron D, Maxwell A, Corp DT, Silk TJ.

Neurosci Biobehav Rev. 2024 Aug;163:105779. doi: 10.1016/j.neubiorev.2024.105779. Epub 2024 Jun 25.

Adenylyl cyclase 2 expression and function in neurological diseases

Gray M, Nash KR, Yao Y.

CNS Neurosci Ther. 2024 Jul;30(7):e14880. doi: 10.1111/cns.14880.

Co-occurring Epilepsy and Attention-Deficit/Hyperactivity Disorder in a 6-Year-Old Boy

Jerskey BA, Reid AA, Spencer K, Diekroger E, Fogler J.

J Dev Behav Pediatr. 2024 Jul-Aug 01;45(4):e387-e389. doi: 10.1097/DBP.0000000000001284. Epub 2024 Jun 19.